20 articles
New research shows diabetes and weight-loss medications slow alcohol absorption, making people feel less intoxicated and potentially reducing drinking.
WHO-commissioned reviews find Ozempic and similar drugs deliver up to 16% weight loss, but long-term safety data remains limited.
New rare sugar sweetener may reduce body fat and blood sugar, but research shows mixed results and potential digestive issues.
New research identifies LRG1 protein as early trigger of diabetic retinopathy, opening door to prevention-based treatments.
Historical and modern evidence suggests fasting can reverse diabetes, but sustainable dietary changes are crucial for lasting results.
Scientists discover how thin mountain air transforms red blood cells into glucose absorbers, explaining lower diabetes rates at elevation.
Large study of 8,000 patients reveals stopping GLP-1 drugs doesn't guarantee weight regain as many restart treatment or adopt lifestyle changes.
New research shows extreme calorie restriction alone matches bariatric surgery's diabetes reversal benefits without surgical risks.
Experimental diabetes drug IC7Fc reduces cholesterol and artery plaque buildup, offering cardiovascular benefits even without weight loss.
New research shows blood sugar can normalize without losing weight by shifting harmful belly fat to healthier locations under the skin.
New research shows ketogenic diet helps normalize blood sugar and dramatically improves muscle response to exercise in mice.
Researchers discover how SLIT3 protein helps brown fat build blood vessels and nerves needed to burn calories instead of storing them as fat.
UC Riverside scientists developed a gel that delivers continuous oxygen to chronic wounds, healing fatal injuries in diabetic mice within weeks.
Scientists discover vitamin B3 can target a key genetic driver of fatty liver disease, offering hope for 30% of people affected globally.
Three new NIH-funded findings tackle metabolic aging, cardiovascular risk, and a surprising hormonal brake on brain tumors.
New research reveals how gut cells communicate with your brain to shut down appetite during infection through a two-phase signaling process.
Three NIH-funded studies this week tackle metabolic decline, cardiac risk, and brain tumors — all with aging implications.
New research reveals how gut cells communicate with your brain to shut down appetite during infection through a two-phase signaling process.
Reducing methionine and cysteine in diet activated calorie-burning beige fat as effectively as cold exposure, offering new weight loss insights.
Scientists discover vitamin B3 can target a key genetic driver of fatty liver disease, offering hope for a safe, accessible treatment.
